Uploaded February 2023 | Updated November 2026, 10 hours ago
How is the growing synthetic biology sector evolving, why is it growing exponentially, and what are key players doing to stake their claim in an already crowded field that’s spurring an industry transition toward greater sustainability?
Together Hello Tomorrow and Solvay hosted a virtual panel discussion on February 14th, 2023 to hear industry leaders share their experiences in biotech and their unique perspectives on start-up trends, how ideas can be transformed into high-value ventures, and some new venture capital funding opportunities for entrepreneurs.
Use cases:
Early-stage startup DMC Biotechnologies and the trials and triumphs they’ve faced in turning their idea into an innovation, developing new technology applications, building plants, and scaling up production capacities
Learn how a mature start-up, Ginkgo, took an idea from the lab to the pilot plant to gain commercial traction and land its billion-dollar valuation. And why are more and more big corporations like Solvay collaborating with new entrepreneurs to help early-stage start-ups seed and grow, improve their technology, and develop the full-throated value proposition it takes to play successfully in this sector?
Panelists:
Thomas Canova - Head of Solvay Circular Materials, Biotechnology, and Solvay Ventures
Matt Lipscomb, PhD - CEO and Founder of DMC Biotechnologies
Po Bronson - General Partner at SOSV & Managing Director at IndieBio
Kevin Madden, VP Business Development, at Ginkgo Bioworks, Inc, a startup helping grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more.
Moderated by Rainbow Lo, PhD, Chemistry & Materials Expert, Hello Tomorrow
If you're interested in Solvay Ventures' newest initiatives, visit solvay.com/en/innovation/solvay-ventures
If you have questions about the webinar topics you can send them to contact@hello-tomorrow.org
To never miss out on Hello Tomorrow's webinars, sign up to our newsletter: bit.ly/HelloTomorrowNewsletter3XzyFW2
How is the growing synthetic biology sector evolving, why is it growing exponentially, and what are key players doing to stake their claim in an already crowded field that’s spurring an industry transition toward greater sustainability?
Together Hello Tomorrow and Solvay hosted a virtual panel discussion on February 14th, 2023 to hear industry leaders share their experiences in biotech and their unique perspectives on start-up trends, how ideas can be transformed into high-value ventures, and some new venture capital funding opportunities for entrepreneurs.
Use cases:
Early-stage startup DMC Biotechnologies and the trials and triumphs they’ve faced in turning their idea into an innovation, developing new technology applications, building plants, and scaling up production capacities
Learn how a mature start-up, Ginkgo, took an idea from the lab to the pilot plant to gain commercial traction and land its billion-dollar valuation. And why are more and more big corporations like Solvay collaborating with new entrepreneurs to help early-stage start-ups seed and grow, improve their technology, and develop the full-throated value proposition it takes to play successfully in this sector?
Panelists:
Thomas Canova - Head of Solvay Circular Materials, Biotechnology, and Solvay Ventures
Matt Lipscomb, PhD - CEO and Founder of DMC Biotechnologies
Po Bronson - General Partner at SOSV & Managing Director at IndieBio
Kevin Madden, VP Business Development, at Ginkgo Bioworks, Inc, a startup helping grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more.
Moderated by Rainbow Lo, PhD, Chemistry & Materials Expert, Hello Tomorrow
If you're interested in Solvay Ventures' newest initiatives, visit solvay.com/en/innovation/solvay-ventures
If you have questions about the webinar topics you can send them to contact@hello-tomorrow.org
To never miss out on Hello Tomorrow's webinars, sign up to our newsletter: bit.ly/HelloTomorrowNewsletter3XzyFW2










